Topical Application of Tranexamic Acid to Reduce Post-operative Bleeding in Coronary Artery Bypass Surgery
Status:
Completed
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
The goal of this project is to determine whether the use of tranexamic acid, a clot-promoting
drug, applied topically over the heart in coronary artery bypass graft surgery (CABG) will
reduce post operative blood loss. The investigators' hypothesis is that the use of a
tranexamic acid-containing cardiac bath prior to chest closure will result in a statistically
significant reduction in blood loss and transfusion requirements in patients who undergo
CABG.